130 related articles for article (PubMed ID: 29425029)
1. Mechanistic Origins of Enzyme Activation in Human Glucokinase Variants Associated with Congenital Hyperinsulinism.
Sternisha SM; Liu P; Marshall AG; Miller BG
Biochemistry; 2018 Mar; 57(10):1632-1639. PubMed ID: 29425029
[TBL] [Abstract][Full Text] [Related]
2. Dual allosteric activation mechanisms in monomeric human glucokinase.
Whittington AC; Larion M; Bowler JM; Ramsey KM; Brüschweiler R; Miller BG
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11553-8. PubMed ID: 26283387
[TBL] [Abstract][Full Text] [Related]
3. Order-disorder transitions govern kinetic cooperativity and allostery of monomeric human glucokinase.
Larion M; Salinas RK; Bruschweiler-Li L; Miller BG; Brüschweiler R
PLoS Biol; 2012; 10(12):e1001452. PubMed ID: 23271955
[TBL] [Abstract][Full Text] [Related]
4. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
[TBL] [Abstract][Full Text] [Related]
5. Nitric Oxide Activates β-Cell Glucokinase by Promoting Formation of the "Glucose-Activated" State.
Seckinger KM; Rao VP; Snell NE; Mancini AE; Markwardt ML; Rizzo MA
Biochemistry; 2018 Aug; 57(34):5136-5144. PubMed ID: 30053375
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations.
Li C; Juliana CA; Yuan Y; Li M; Lu M; Chen P; Boodhansingh KE; Doliba NM; Bhatti TR; Adzick NS; Stanley CA; De León DD
Diabetes; 2023 Dec; 72(12):1809-1819. PubMed ID: 37725835
[TBL] [Abstract][Full Text] [Related]
7. Role of connecting loop I in catalysis and allosteric regulation of human glucokinase.
Martinez JA; Larion M; Conejo MS; Porter CM; Miller BG
Protein Sci; 2014 Jul; 23(7):915-22. PubMed ID: 24723372
[TBL] [Abstract][Full Text] [Related]
8. The novel GCK variant p.Val455Leu associated with hyperinsulinism is susceptible to allosteric activation and is conducive to weight gain and the development of diabetes.
Langer S; Waterstradt R; Hillebrand G; Santer R; Baltrusch S
Diabetologia; 2021 Dec; 64(12):2687-2700. PubMed ID: 34532767
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
[TBL] [Abstract][Full Text] [Related]
10. Activating glucokinase (GCK) mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation.
Christesen HB; Tribble ND; Molven A; Siddiqui J; Sandal T; Brusgaard K; Ellard S; Njølstad PR; Alm J; Brock Jacobsen B; Hussain K; Gloyn AL
Eur J Endocrinol; 2008 Jul; 159(1):27-34. PubMed ID: 18450771
[TBL] [Abstract][Full Text] [Related]
11. Nanosecond-Timescale Dynamics and Conformational Heterogeneity in Human GCK Regulation and Disease.
Sternisha SM; Whittington AC; Martinez Fiesco JA; Porter C; McCray MM; Logan T; Olivieri C; Veglia G; Steinbach PJ; Miller BG
Biophys J; 2020 Mar; 118(5):1109-1118. PubMed ID: 32023434
[TBL] [Abstract][Full Text] [Related]
12. 23-Residue C-terminal alpha-helix governs kinetic cooperativity in monomeric human glucokinase.
Larion M; Miller BG
Biochemistry; 2009 Jul; 48(26):6157-65. PubMed ID: 19473033
[TBL] [Abstract][Full Text] [Related]
13. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular regulation of human glucokinase.
Sternisha SM; Miller BG
Arch Biochem Biophys; 2019 Mar; 663():199-213. PubMed ID: 30641049
[TBL] [Abstract][Full Text] [Related]
15. Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations.
Gloyn AL; Noordam K; Willemsen MA; Ellard S; Lam WW; Campbell IW; Midgley P; Shiota C; Buettger C; Magnuson MA; Matschinsky FM; Hattersley AT
Diabetes; 2003 Sep; 52(9):2433-40. PubMed ID: 12941786
[TBL] [Abstract][Full Text] [Related]
16. Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene.
Barbetti F; Cobo-Vuilleumier N; Dionisi-Vici C; Toni S; Ciampalini P; Massa O; Rodriguez-Bada P; Colombo C; Lenzi L; Garcia-Gimeno MA; Bermudez-Silva FJ; Rodriguez de Fonseca F; Banin P; Aledo JC; Baixeras E; Sanz P; Cuesta-Muñoz AL
Mol Endocrinol; 2009 Dec; 23(12):1983-9. PubMed ID: 19884385
[TBL] [Abstract][Full Text] [Related]
17. First evidence of changes in enzyme kinetics and stability of glucokinase affected by somatic cancer-associated variations.
Těšínský M; Šimčíková D; Heneberg P
Biochim Biophys Acta Proteins Proteom; 2019 Mar; 1867(3):213-218. PubMed ID: 30590153
[TBL] [Abstract][Full Text] [Related]
18. Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells.
Tornovsky-Babeay S; Dadon D; Ziv O; Tzipilevich E; Kadosh T; Schyr-Ben Haroush R; Hija A; Stolovich-Rain M; Furth-Lavi J; Granot Z; Porat S; Philipson LH; Herold KC; Bhatti TR; Stanley C; Ashcroft FM; In't Veld P; Saada A; Magnuson MA; Glaser B; Dor Y
Cell Metab; 2014 Jan; 19(1):109-21. PubMed ID: 24332968
[TBL] [Abstract][Full Text] [Related]
19. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.
Gloyn AL
Hum Mutat; 2003 Nov; 22(5):353-62. PubMed ID: 14517946
[TBL] [Abstract][Full Text] [Related]
20. Conformational heterogeneity and intrinsic disorder in enzyme regulation: Glucokinase as a case study.
Larion M; Miller B; Brüschweiler R
Intrinsically Disord Proteins; 2015; 3(1):e1011008. PubMed ID: 28232887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
